FUNDAMENTALS · Fundamentals · JP Healthcare

Create SD Holdings (3148) Fundamentals 2026 — P/E 12.7x, Revenue Analysis | SniperIQ

Create SD Holdings (3148) is a JP-listed Healthcare company in Medical - Pharmaceuticals with a market capitalization of ¥215.1B, trading at ¥3330.00 on the JPX. This SniperIQ fundamentals page covers Create SD Holdings's valuation (P/E 12.7x, P/B 1.4x), profitability (net margin 3.4%), revenue (¥497.1B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap¥215.1B
P/E (TTM)12.7x
Net Margin3.4%
Revenue (FY25)¥497.1B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Create SD Holdings's market cap?

Create SD Holdings (3148) has a market capitalization of approximately ¥215.1B, trading at ¥3330.00 on the JPX. Market cap moves with the live share price.

What is Create SD Holdings's P/E ratio?

Create SD Holdings's trailing twelve-month P/E ratio is 12.7x, with a price-to-book (P/B) of 1.4x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Create SD Holdings?

Create SD Holdings runs a net profit margin of 3.4%, a gross margin of 24.9%, and an operating margin of 4.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Create SD Holdings generate?

Create SD Holdings reported revenue of ¥497.1B for fiscal year 2025, with net income of ¥17.0B and earnings per share (EPS) of 262.99. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Create SD Holdings pay a dividend?

Create SD Holdings offers a trailing dividend yield of about 2.8%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is Create SD Holdings financially healthy?

Create SD Holdings carries a debt-to-equity ratio of 0.01x and a current ratio of 1.29x, with a market beta of 0.14. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Create SD Holdings a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Create SD Holdings (3148) the key facts are: market cap ¥215.1B, P/E 12.7x, revenue ¥497.1B, 52-week range 3090-3595. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Create SD Holdings's full fundamentals live

Get Create SD Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: JMDC (4483) fundamentals · Novo Nordisk (NVO) fundamentals · Bio Plus (099430) fundamentals · Granules India (GRANULES) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons